Potential risks of cell-free concentrated ascites reinfusion therapy in TAFRO syndrome patient

被引：0
|
作者：
Satoh, Kasumi [1 ,2 ]
Okuyama, Manabu [1 ]
Nakae, Hajime [1 ]
机构：
[1] Akita Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Akita, Japan
[2] Akita Univ, Grad Sch Med, Dept Emergency & Crit Care Med, 1-1-1 Hondo, Akita 0108543, Japan
来源：
THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 03期
关键词：
D O I：
10.1111/1744-9987.14109
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：477 / 478
页数：2
相关论文
共 50 条
  • [21] Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System-Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration (vol 23, pg 233, 2019)
    Yoshizawa, M.
    Nakatsuji, Y.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (06) : 586 - 586
  • [22] Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
    Itagaki, Hideya
    Katuhiko, Suzuki
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [23] Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
    Hideya Itagaki
    Suzuki Katuhiko
    Journal of Medical Case Reports, 15
  • [24] Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites
    Ito, Tetsuya
    Hanafusa, Norio
    Soneda, Noriko
    Isoai, Ayako
    Kobayashi, Ryosuke
    Torii, Naoko
    Kato, Michio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3224 - 3232
  • [25] Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites
    Wang, Liangcheng
    Okubo, Takashi
    Shinsaka, Mamiko
    Kobayashi, Akiko
    Ogasawara, Miwa
    Sakaguchi, Riko
    Nagai, Tomonori
    Seki, Hiroyuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (10) : 1614 - 1620
  • [26] APPLICATION OF KM-CART (ADVANCED CELL-FREE AND CONCENTRATED ASCITES REINFUSION THERAPY) TREATMENT TO PATIENTS WITH CANCEROUS ASCITES
    Matsusaki, K.
    Ohta, K.
    Yoshizawa, A.
    Goto, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 463 - 464
  • [27] Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
    Iwasa, Motoh
    Ishihara, Tomoaki
    Kato, Michio
    Isoai, Ayako
    Kobayashi, Ryosuke
    Torii, Naoko
    Soneda, Noriko
    Takei, Yoshiyuki
    INTERNAL MEDICINE, 2019, 58 (21) : 3069 - 3075
  • [28] PREVENTION OF THE FEBRILE REACTION OCCURRING ON REINFUSION OF CELL-FREE AND CONCENTRATED AUTOGENOUS ASCITES
    KATOH, S
    TATSUKAWA, H
    KONDOH, M
    INOUE, M
    IDA, K
    MIYAGAWA, F
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (04) : 311 - 317
  • [29] Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites
    Yoshiko Kawata
    Kazunori Nagasaka
    Yoko Matsumoto
    Katsutoshi Oda
    Michihiro Tanikawa
    Kenbun Sone
    Mayuyo Mori-Uchino
    Tetsushi Tsuruga
    Takahide Arimoto
    Yutaka Osuga
    Tomoyuki Fujii
    International Journal of Clinical Oncology, 2019, 24 : 420 - 427
  • [30] The utility of cell free and concentrated ascites reinfusion therapy in gastroenterological cancer
    Ueda, Masami
    Ikenaga, Masakazu
    Ohta, Katsuya
    Sato, Go
    Sakai, Takaaki
    Chinen, Yoshinao
    Itakura, Hiroaki
    Kato, Ryo
    Iede, Kiyotsugu
    Tsuda, Yujiro
    Nakashima, Shinsuke
    Endo, Shunji
    Yamada, Terumasa
    CANCER SCIENCE, 2018, 109 : 1014 - 1014
12345